Internal Medicine, Nephrology · Pharr, TX
NPI
1558334177
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
214 W Sam Houston Blvd Ste B
Pharr, TX, 78577
Phone (956) 971-9121
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
714 services
Medicare patients, 2024
144
Average age 70
Drug cost, 2024
$1.4M
2,758 prescriptions
Company payments, 2025
$20.22
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Savita Koolwal was code 99214 (office e&m - established), 175 times for 64 patients. In total Savita Koolwal billed 714 services in 22 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 175 | 64 | $85.94 | $15K |
| 90960 ESRD Related Services (not dialysis) | Office | 140 | 20 | $256.36 | $36K |
| 99232 Hospital E&M - Subsequent | Facility | 102 | 42 | $59.83 | $6,102 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 86 | 38 | $12.40 | $1,067 |
| 99233 Hospital E&M - Subsequent | Facility | 40 | 14 | $88.76 | $3,550 |
| 99223 Hospital E&M - Initial | Facility | 32 | 28 | $127.26 | $4,072 |
| 36415 Venipuncture Blood Collection | Office | 22 | 19 | $8.65 | $190 |
| 99204 Office E&M - New | Office | 20 | 20 | $113.91 | $2,278 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 11 | 11 | $81.08 | $892 |
By year: 2022 $106K for 774 services; 2023 $91K for 649 services; 2024 $82K for 714 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 22 | 19 | $8.65 | $190 |
Medicare prescription drug claims, 2024
In 2024, the drug Savita Koolwal prescribed most often to Medicare patients was Prosol (Parenteral Amino Acid 20% No.1), with 206 prescriptions and refills. In total Savita Koolwal wrote 2,758 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prosol Parenteral Amino Acid 20% No.1 | 206 | 206 | Under 11 | $40K |
| Lokelma Sodium Zirconium Cyclosilicate | 201 | 287 | 58 | $207K |
| Farxiga Dapagliflozin Propanediol | 192 | 359 | 62 | $187K |
| Furosemide Generic | 143 | 278 | 44 | $444 |
| Sevelamer Carbonate Generic | 133 | 288 | 48 | $51K |
| Amlodipine Besylate Generic | 120 | 296 | 47 | $544 |
| Jardiance Empagliflozin | 118 | 232 | 37 | $126K |
| Kerendia Finerenone | 112 | 175 | 26 | $107K |
| Losartan Potassium Generic | 97 | 259 | 47 | $939 |
| Allopurinol Generic | 95 | 236 | 32 | $675 |
| Nifedipine Er Nifedipine | 74 | 163 | 29 | $2,356 |
| Xphozah Tenapanor Hcl | 64 | 68 | 13 | $194K |
| Clinisol Parenteral Amino Acid 15% No.5 | 54 | 54 | Under 11 | $9,086 |
| Lisinopril Generic | 47 | 128 | 20 | $342 |
| Calcitriol Generic | 46 | 107 | 14 | $870 |
Brand drugs: 1,174 claims; generic drugs: 1,567 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Savita Koolwal $20.22 ($20.22 in general payments such as food, travel and fees) from 1 company. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $20.22.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $20.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.